Spreading of Tau Protein Does Not Depend on Aggregation Propensity

IF 2.8 4区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Sara Rodrigues, Marta Anglada-Huguet, Katja Hochgräfe, Senthilvelrajan Kaniyappan, Susanne Wegmann, Eva-Maria Mandelkow
{"title":"Spreading of Tau Protein Does Not Depend on Aggregation Propensity","authors":"Sara Rodrigues,&nbsp;Marta Anglada-Huguet,&nbsp;Katja Hochgräfe,&nbsp;Senthilvelrajan Kaniyappan,&nbsp;Susanne Wegmann,&nbsp;Eva-Maria Mandelkow","doi":"10.1007/s12031-023-02143-w","DOIUrl":null,"url":null,"abstract":"<div><p>The stereotypical progression of Tau pathology during Alzheimer disease has been attributed to trans-neuronal spreading of misfolded Tau proteins, followed by prion-like templated aggregation of Tau. The nature of Tau and the cellular mechanisms of Tau spreading are still under debate. We hypothesized that Tau’s propensity for aggregation would correlate with its ability to spread across synapses and propagate pathology. To study the progressive propagation of Tau proteins in brain regions relevant for Alzheimer disease, we used mice expressing near-physiological levels of full-length human Tau protein carrying pro-aggregant (TauΔK280, Tau<sup>ΔK</sup>) or anti-aggregant (TauΔK280-PP, Tau<sup>ΔK−PP</sup>) mutations in the entorhinal cortex (EC). To enhance Tau expression in the EC, we performed EC injections of adeno-associated virus (AAV) particles encoding Tau<sup>ΔK</sup> or Tau<sup>ΔK−PP</sup>. The brains of injected and non-injected EC/Tau<sup>ΔK</sup> and EC/Tau<sup>ΔK−PP</sup> mice were studied by immunohistological and biochemical techniques to detect Tau propagation to dentate gyrus (DG) neurons and Tau-induced pathological changes. Pro- and anti-aggregant mice had comparable low transgene expression (~0.2 times endogenous mouse Tau). They accumulated human Tau at similar rates and only in expressing EC neurons, including their axonal projections of the perforant path and presynaptic terminals in the molecular layer of the DG. Pro-aggregant EC/Tau<sup>ΔK</sup> mice showed misfolded Tau and synaptic protein alterations in EC neurons, not observed in anti-aggregant EC/Tau<sup>ΔK−PP</sup> mice. Additional AAV-mediated expression of Tau<sup>ΔK</sup> or Tau<sup>ΔK−PP</sup> in EC/Tau<sup>ΔK</sup> or EC/Tau<sup>ΔK−PP</sup> mice, respectively, increased the human Tau expression to ~0.65 times endogenous mouse Tau, with comparable spreading of Tau<sup>ΔK</sup> and Tau<sup>ΔK−PP</sup> throughout the EC. There was a low level of transcellular propagation of Tau protein, without pathological phosphorylation or misfolding, as judged by diagnostic antibodies. Additionally, Tau<sup>ΔK</sup> but not Tau<sup>ΔK−PP</sup> expression induced hippocampal astrogliosis. Low levels of pro- or anti-aggregant full-length Tau show equivalent distributions in EC neurons, independent of their aggregation propensity. Increasing the expression via AAV induce local Tau misfolding in the EC neurons, synaptotoxicity, and astrogliosis and lead to a low level of detectable trans-neuronal spreading of Tau. This depends on its concentration in the EC, but, contrary to expectations, does not depend on Tau’s aggregation propensity/misfolding and does not lead to templated misfolding in recipient neurons.</p></div>","PeriodicalId":652,"journal":{"name":"Journal of Molecular Neuroscience","volume":"73 9-10","pages":"693 - 712"},"PeriodicalIF":2.8000,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694122/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12031-023-02143-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

The stereotypical progression of Tau pathology during Alzheimer disease has been attributed to trans-neuronal spreading of misfolded Tau proteins, followed by prion-like templated aggregation of Tau. The nature of Tau and the cellular mechanisms of Tau spreading are still under debate. We hypothesized that Tau’s propensity for aggregation would correlate with its ability to spread across synapses and propagate pathology. To study the progressive propagation of Tau proteins in brain regions relevant for Alzheimer disease, we used mice expressing near-physiological levels of full-length human Tau protein carrying pro-aggregant (TauΔK280, TauΔK) or anti-aggregant (TauΔK280-PP, TauΔK−PP) mutations in the entorhinal cortex (EC). To enhance Tau expression in the EC, we performed EC injections of adeno-associated virus (AAV) particles encoding TauΔK or TauΔK−PP. The brains of injected and non-injected EC/TauΔK and EC/TauΔK−PP mice were studied by immunohistological and biochemical techniques to detect Tau propagation to dentate gyrus (DG) neurons and Tau-induced pathological changes. Pro- and anti-aggregant mice had comparable low transgene expression (~0.2 times endogenous mouse Tau). They accumulated human Tau at similar rates and only in expressing EC neurons, including their axonal projections of the perforant path and presynaptic terminals in the molecular layer of the DG. Pro-aggregant EC/TauΔK mice showed misfolded Tau and synaptic protein alterations in EC neurons, not observed in anti-aggregant EC/TauΔK−PP mice. Additional AAV-mediated expression of TauΔK or TauΔK−PP in EC/TauΔK or EC/TauΔK−PP mice, respectively, increased the human Tau expression to ~0.65 times endogenous mouse Tau, with comparable spreading of TauΔK and TauΔK−PP throughout the EC. There was a low level of transcellular propagation of Tau protein, without pathological phosphorylation or misfolding, as judged by diagnostic antibodies. Additionally, TauΔK but not TauΔK−PP expression induced hippocampal astrogliosis. Low levels of pro- or anti-aggregant full-length Tau show equivalent distributions in EC neurons, independent of their aggregation propensity. Increasing the expression via AAV induce local Tau misfolding in the EC neurons, synaptotoxicity, and astrogliosis and lead to a low level of detectable trans-neuronal spreading of Tau. This depends on its concentration in the EC, but, contrary to expectations, does not depend on Tau’s aggregation propensity/misfolding and does not lead to templated misfolding in recipient neurons.

Abstract Image

Tau蛋白的扩散不依赖于聚集倾向。
阿尔茨海默病期间Tau病理的典型进展归因于错误折叠的Tau蛋白的跨神经元扩散,随后是朊病毒样的Tau模板聚集。Tau蛋白的性质和Tau蛋白扩散的细胞机制仍在争论中。我们假设Tau蛋白的聚集倾向与其在突触间扩散和传播病理的能力有关。为了研究Tau蛋白在与阿尔茨海默病相关的大脑区域的进行性增殖,我们使用了在内嗅皮层(EC)表达接近生理水平的全长人Tau蛋白携带促聚集(TauΔK280, TauΔK)或抗聚集(TauΔK280-PP, TauΔK-PP)突变的小鼠。为了增强Tau蛋白在EC中的表达,我们将编码TauΔK或TauΔK-PP的腺相关病毒(AAV)颗粒注射到EC中。采用免疫组织学和生化技术研究注射和未注射EC/TauΔK和EC/TauΔK-PP小鼠的大脑,检测Tau向齿状回(DG)神经元的增殖和Tau诱导的病理改变。亲聚集和抗聚集小鼠的转基因表达水平相当低(约为内源性小鼠Tau的0.2倍)。它们以相似的速度积累人类Tau蛋白,并且只在表达EC神经元中积累,包括它们在DG分子层的穿透路径和突触前末端的轴突投射。亲聚集EC/TauΔK小鼠在EC神经元中显示错误折叠的Tau蛋白和突触蛋白改变,而在抗聚集EC/TauΔK-PP小鼠中未观察到。在EC/TauΔK或EC/TauΔK-PP小鼠中,aav介导的TauΔK或TauΔK-PP的额外表达分别使人Tau的表达增加到内源性小鼠Tau的约0.65倍,TauΔK和TauΔK-PP在整个EC中的传播相当。诊断抗体判断,Tau蛋白的跨细胞增殖水平低,无病理性磷酸化或错误折叠。此外,TauΔK而不是TauΔK-PP表达诱导海马星形胶质细胞增生。低水平的支持或反对聚集的全长Tau在EC神经元中显示出相同的分布,独立于它们的聚集倾向。通过AAV增加表达可诱导EC神经元中Tau的局部错误折叠、突触毒性和星形胶质细胞形成,并导致Tau的低水平可检测的跨神经元扩散。这取决于其在EC中的浓度,但与预期相反,并不取决于Tau的聚集倾向/错误折叠,也不会导致受体神经元中的模板错误折叠。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Molecular Neuroscience
Journal of Molecular Neuroscience 医学-神经科学
CiteScore
6.60
自引率
3.20%
发文量
142
审稿时长
1 months
期刊介绍: The Journal of Molecular Neuroscience is committed to the rapid publication of original findings that increase our understanding of the molecular structure, function, and development of the nervous system. The criteria for acceptance of manuscripts will be scientific excellence, originality, and relevance to the field of molecular neuroscience. Manuscripts with clinical relevance are especially encouraged since the journal seeks to provide a means for accelerating the progression of basic research findings toward clinical utilization. All experiments described in the Journal of Molecular Neuroscience that involve the use of animal or human subjects must have been approved by the appropriate institutional review committee and conform to accepted ethical standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信